Hot Topics in. Thursday, October 5, Register Online! VindicoCME.com/ CASE CHOICE. Interactive Dinner Symposium 2.0.

Transcription

1 Clinical Chief, /-certified Activity /-certified Activity This continuing

2 Audience-driven, -based Learning Customized learning at your fingertips you choose case! Overview Agenda Antiretroviral rapy has improved dramatically over past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to already diverse field of HIV. Clinicians must keep up with new data on treatment strategies, selection of appropriate individualized rapy, and effective management of patient side effects. In this interactive, case-based program, expert faculty will convey how to incorporate new treatment strategies into clinical practice and discuss various aspects of HIV management, including selecting an initial antiretroviral regimen, modifying rapy in virologically suppressed patients, and selecting optimal approach for those with treatment failure. 6:00 pm 6:10 pm Introduction and Pretest 6:10 pm 6:30 pm 6:30 pm 6:45 pm Determining Most Appropriate Initial Treatment 6:45 pm 6:50 pm 6:50 pm 7:05 pm Switching ART in Virologic Suppression Learning Objectives Upon successful completion of this activity, participants should be better able to: 7:05 pm 7:10 pm 7:10 pm 7:25 pm Managing Treatment experienced HIV Patients with Virologic Failure Apply updated evidence-based guidelines and recommendations when selecting initial treatment for patients with HIV. Select and optimize HIV treatment regimens based on clinical safety and efficacy, propensity for resistance, and patient characteristics. 7:25 pm 7:30 pm 7:30 pm 7:45 pm Panel Discussion 7:45 pm 8:00 pm Posttest and Question and Answer Meeting Adjournment 8:00 pm Consider patient preferences when selecting HIV treatment regimens to increase adherence and compliance to rapy. Implement effective switching strategies, as necessary, in patients who are virologically suppressed, have become virologically resistant to rapy, or have become nonadherent. National Jewish Health is accredited by Accreditation Council for Continuing Medical Education to provide continuing for physicians. National Jewish Health designates this live activity for a maximum of AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with extent of ir participation in activity. Vindico Medical Education is accredited by Accreditation Council for Pharmacy Education (A) as a provider of continuing pharmacy education. Target Audience 2017 istockphoto.com/billnoll; EzumeImages What s New in HIV Treatment: Finding Best Options This program is acceptable for contact hours of A Continuing Education Credit. The A Universal Program Number is L02-P, effective 10/5/2017. This is an applicationbased activity and re is no fee to attend. The intended audience for this activity is infectious disease specialists, HIV treaters, pharmacists, and or health care professionals involved in treatment of patients with HIV. To receive credit, physicians and pharmacists must attend entire presentation and complete evaluation at end of program. Credit Claim Forms will be available onsite. In accordance with Accreditation Council for Continuing Medical Education and Accreditation Council for Pharmacy Education s Standards for Commercial Support, all planners, speakers, reviewers, and staff involved in development of / content are required to disclose to accredited provider ir relevant financial relationships. Relevant financial relationships will be disclosed to activity audience. All activity participants will be informed if any speakers/authors intend to discuss eir non-fda approved or investigational uses of any products/devices. Thursday, October 5, 2017 Lobby Level, North Tower San Diego, CA /-certified Activity MeetingRegistration@Vindico.com Toll-free: , ext. 219 or 476 Phone: , ext. 219 or 476 Fax: Mail: Registration Department 6900 Grove Road Priority Code: First Name M.I. Last Name Preferred Mailing Address (Home/Business) City State Zip Code Country Daytime Phone Evening Phone Fax Date of Birth Contact Information: (for tracking credits ONLY) National Provider Identifier (NPI) Medical License Number Medical License State Degree (please specify) q MD/DO q PhD q MD, PhD q PharmD/RPh q PA q RN/BSN/MSN q NP q Industry q Or: How did you hear about this meeting? (multiple selections allowed) q q Advertisement q Postcard q Brochure q Web site q Word of mouth Specialty (select one) q Infectious Disease q Internal Medicine q HIV/AIDS q Pharmacy q Or: / Activity Request q YES, I would like to receive information regarding future / activities related to this rapeutic area. ADA compliance: In compliance with Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests.

3 Clinical Chief, /-certified Activity /-certified Activity This continuing

4 Audience-driven, -based Learning Customized learning at your fingertips you choose case! Overview Agenda Antiretroviral rapy has improved dramatically over past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to already diverse field of HIV. Clinicians must keep up with new data on treatment strategies, selection of appropriate individualized rapy, and effective management of patient side effects. In this interactive, case-based program, expert faculty will convey how to incorporate new treatment strategies into clinical practice and discuss various aspects of HIV management, including selecting an initial antiretroviral regimen, modifying rapy in virologically suppressed patients, and selecting optimal approach for those with treatment failure. 6:00 pm 6:10 pm Introduction and Pretest 6:10 pm 6:30 pm 6:30 pm 6:45 pm Determining Most Appropriate Initial Treatment 6:45 pm 6:50 pm 6:50 pm 7:05 pm Switching ART in Virologic Suppression Learning Objectives Upon successful completion of this activity, participants should be better able to: 7:05 pm 7:10 pm 7:10 pm 7:25 pm Managing Treatment experienced HIV Patients with Virologic Failure Apply updated evidence-based guidelines and recommendations when selecting initial treatment for patients with HIV. Select and optimize HIV treatment regimens based on clinical safety and efficacy, propensity for resistance, and patient characteristics. 7:25 pm 7:30 pm 7:30 pm 7:45 pm Panel Discussion 7:45 pm 8:00 pm Posttest and Question and Answer Meeting Adjournment 8:00 pm Consider patient preferences when selecting HIV treatment regimens to increase adherence and compliance to rapy. Implement effective switching strategies, as necessary, in patients who are virologically suppressed, have become virologically resistant to rapy, or have become nonadherent. National Jewish Health is accredited by Accreditation Council for Continuing Medical Education to provide continuing for physicians. National Jewish Health designates this live activity for a maximum of AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with extent of ir participation in activity. Vindico Medical Education is accredited by Accreditation Council for Pharmacy Education (A) as a provider of continuing pharmacy education. Target Audience 2017 istockphoto.com/billnoll; EzumeImages What s New in HIV Treatment: Finding Best Options This program is acceptable for contact hours of A Continuing Education Credit. The A Universal Program Number is L02-P, effective 10/5/2017. This is an applicationbased activity and re is no fee to attend. The intended audience for this activity is infectious disease specialists, HIV treaters, pharmacists, and or health care professionals involved in treatment of patients with HIV. To receive credit, physicians and pharmacists must attend entire presentation and complete evaluation at end of program. Credit Claim Forms will be available onsite. In accordance with Accreditation Council for Continuing Medical Education and Accreditation Council for Pharmacy Education s Standards for Commercial Support, all planners, speakers, reviewers, and staff involved in development of / content are required to disclose to accredited provider ir relevant financial relationships. Relevant financial relationships will be disclosed to activity audience. All activity participants will be informed if any speakers/authors intend to discuss eir non-fda approved or investigational uses of any products/devices. Thursday, October 5, 2017 Lobby Level, North Tower San Diego, CA /-certified Activity MeetingRegistration@Vindico.com Toll-free: , ext. 219 or 476 Phone: , ext. 219 or 476 Fax: Mail: Registration Department 6900 Grove Road Priority Code: First Name M.I. Last Name Preferred Mailing Address (Home/Business) City State Zip Code Country Daytime Phone Evening Phone Fax Date of Birth Contact Information: (for tracking credits ONLY) National Provider Identifier (NPI) Medical License Number Medical License State Degree (please specify) q MD/DO q PhD q MD, PhD q PharmD/RPh q PA q RN/BSN/MSN q NP q Industry q Or: How did you hear about this meeting? (multiple selections allowed) q q Advertisement q Postcard q Brochure q Web site q Word of mouth Specialty (select one) q Infectious Disease q Internal Medicine q HIV/AIDS q Pharmacy q Or: / Activity Request q YES, I would like to receive information regarding future / activities related to this rapeutic area. ADA compliance: In compliance with Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests.

5 Clinical Chief, /-certified Activity /-certified Activity This continuing